Open AccessXIVth World Congress of Pharmacology, San Francisco, CA, USA July 7–12, 2002 New Drugs for the Treatment of Central Nervous System Disorders
Author(s) -
Scriabine Alexander
Publication year - 2002
Publication title -
cns drug reviews
Language(s) - English
Resource type - Journals
eISSN - 1527-3458
pISSN - 1080-563X
DOI - 10.1111/j.1527-3458.2002.tb00238.x
Subject(s) - convention , library science , medicine , clinical pharmacology , pharmacology , political science , law , computer science
The XIVth World Congress of Pharmacology took place on July 7–12 in Moscone Convention Center, San Francisco, CA. Over 4,000 scientists, exhibitors and guests attended the Congress. It consisted of 40 symposia, 11 workshops, 18 plenary lectures and ca. 1400 posters. The Congress was sponsored by the American Society for Pharmacology and Experimental Therapeutics, Inspire Pharmaceuticals, and GlaxoSmithKline. The major financial donors were: Eli Lilly and Company, Servier, Johnson & Johnson, Merck, Novartis, Roche, Schering‐Plough, Wyeth, and Yamanouchi Foundation. This report covers only posters or presentations on new drugs affecting the central nervous system that were viewed or attended by the author.